Skip to main content
Clinical Trials/DRKS00013027
DRKS00013027
Completed
未知

Sensorimotor- and whole-body vibration training have the potential to reduce motor- and sensory symptoms of Chemotherapy-induced peripheral neuropathy – a randomized controlled trial - VICE

Deutsche Sporthochschule Köln, Universität Basel0 sites40 target enrollmentNovember 6, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Chemotherapy-induced peripheral neuropathy (CIPN)
Sponsor
Deutsche Sporthochschule Köln, Universität Basel
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 6, 2017
End Date
June 17, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Deutsche Sporthochschule Köln, Universität Basel

Eligibility Criteria

Inclusion Criteria

  • \= 18 years old,
  • oncological disease,
  • Chemotherapy\-induced peripheral neuropathy \= grade 1,
  • healthy controls have to have the same age (\+/\- 1 year) and gender

Exclusion Criteria

  • \- neuropathy of other derivation (Diabetes, HIV etc)
  • \- All Illnesses that prevent physical activity
  • \- Contraindications for whole body vibration (Osteosynthesis, instable osteolysis, acute thrombosis, acute prolaps, implants in lower body, pregnancy, acute wounds, fracture of lower extremity in past 2 years etc
  • \- planed operation
  • \- no signed consent or willingness to allow anonymous data collection
  • \- language restrictions or psychological impairments that prevent the understanding of the written consent and/or instructions given
  • \- uncontrolled cerebral fits
  • \- CNS metastatsis

Outcomes

Primary Outcomes

Not specified

Similar Trials